<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04751565</url>
  </required_header>
  <id_info>
    <org_study_id>2021-18/18</org_study_id>
    <nct_id>NCT04751565</nct_id>
  </id_info>
  <brief_title>Analysis of Peri-implant Mucositis With Difference Severity by Means of Non-surgical Subgingival Debridement</brief_title>
  <official_title>Treatment of Peri-implant Mucositis With Difference Severity by Means of Non-surgical Subgingival Debridement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as single center non-randomized prospective comparative study .&#xD;
&#xD;
      Patients with at least one implants with peri-implant mucositis and allocated in three&#xD;
      groups. The implants will be allocated in three groups and treated by means of subgingival&#xD;
      scaling using sonic instrument with plastic tip.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Group A: Presence of BOP-positive within 30 sec (drop or line) at 1-2 sites/implant.&#xD;
&#xD;
      Group B: Presence of BOP-positive within 30 sec (drop or line) at 3-4 sites/implant.&#xD;
&#xD;
      Group C: Presence of BOP-positive within 30 sec (drop or line) at 5-6 sites/implant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2014</start_date>
  <completion_date type="Actual">October 30, 2017</completion_date>
  <primary_completion_date type="Actual">October 25, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Probing depth changes</measure>
    <time_frame>Baseline (T0) and at 6-months (T1)</time_frame>
    <description>Changes over time in probing depth millimiters</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Peri-implant Mucositis</condition>
  <arm_group>
    <arm_group_label>BOP-positive within 30 sec (drop or line) at 1-2 sites/implant Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evaluation of healing of peri-implant mucositis after non-surgical supra and subgingival debridement in patients who presented BOP-positive within 30 sec (drop or line) at 1-2 sites/implant.&#xD;
Primary outcome&#xD;
The primary outcome will be based on probing depth (PD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BOP-positive within 30 sec (drop or line) at 3-4 sites/implant Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evaluation of healing of peri-implant mucositis after non-surgical supra and subgingival debridement in patients who presented BOP-positive within 30 sec (drop or line) at 3-4 sites/implant.&#xD;
Primary outcome&#xD;
The primary outcome will be based on probing depth (PD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BOP-positive within 30 sec (drop or line) at 5-6 sites/implant Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evaluation of healing of peri-implant mucositis after non-surgical supra and subgingival debridement in patients who presented BOP-positive within 30 sec (drop or line) at 5-6 sites/implant.&#xD;
Primary outcome&#xD;
The primary outcome will be based on probing depth (PD)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probing depth reduction following peri-implant therapy</intervention_name>
    <description>Statistically significant different in terms of probing depth (PD) will be recorded between groups.</description>
    <arm_group_label>BOP-positive within 30 sec (drop or line) at 1-2 sites/implant Group</arm_group_label>
    <arm_group_label>BOP-positive within 30 sec (drop or line) at 3-4 sites/implant Group</arm_group_label>
    <arm_group_label>BOP-positive within 30 sec (drop or line) at 5-6 sites/implant Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  age ≥ 18 years&#xD;
&#xD;
          -  non-smokers and smokers ≤ 10 cigarettes/day&#xD;
&#xD;
          -  subjects with gingivitis or treated periodontal conditions (i.e., absence of residual&#xD;
             PPD &gt; 5 mm), peri-implant mucositis defined as ≥ 1 implant site with presence of BoP&#xD;
             and absence of radiographic bone loss compared with a previous radiograph16&#xD;
             ,implant-supported fixed dental prostheses.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  presence of medical conditions contraindicating treatment of peri-implant mucositis,&#xD;
&#xD;
          -  regular use of anti-inflammatory drugs or antibiotics within 3 months prior to study&#xD;
             enrollment&#xD;
&#xD;
          -  pregnant or lactating females&#xD;
&#xD;
          -  removable implant-supported dental prostheses&#xD;
&#xD;
          -  prothesis reconstruction with visible gap between abutment and supra-structure,&#xD;
&#xD;
          -  peri-implantitis, defined as inflammation in the peri-implant mucosa with concomitant&#xD;
             loss of supporting bone .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaetano Isola</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi di Mesina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Messina</name>
      <address>
        <city>Messina</city>
        <zip>98100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 6, 2021</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Gaetano Isola, DDS, PhD</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Sharing study results</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>6-months</ipd_time_frame>
    <ipd_access_criteria>Pubmed website</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

